Akso Health (AHG) Notes Payables (2021 - 2024)

Akso Health has reported Notes Payables for 3 years, with the latest figure at $4.6 million in Q3 2024.

• For the quarter ending Q3 2024, Notes Payables rose 1227.28% year-over-year to $4.6 million; the trailing twelve-month figure through Sep 2024 stood at $4.6 million (up 1227.28% YoY), and the FY2021 full-year result was $10.0 million, changed N/A from the prior year.
• Notes Payables for Q3 2024 stood at $4.6 million, up from $350000.0 in the prior quarter.
• The five-year high for Notes Payables was $10000.0 billion in Q3 2021, with the low at $350000.0 in Q3 2023.
• Historically, Notes Payables has averaged $2500.0 billion across 3 years, with a median of $7.3 million in 2021.
• The largest YoY upside for Notes Payables was 1227.28% in 2024 against a maximum downside of 1227.28% in 2024.
• Akso Health's Notes Payables stood at $10000.0 billion in 2021, then sank by 100.0% to $350000.0 in 2023, then surged by 1227.28% to $4.6 million in 2024.
• The last three Notes Payables figures came in at $4.6 million (Q3 2024), $350000.0 (Q3 2023), and $10000.0 billion (Q3 2021), per Business Quant data.